Study Rationale: As epidemiological research has shown negative effects of high egg consumption on increased all-cause mortality and diabetes and on diabetes outcomes, and egg modification may modulate their effects on diseases risks, it is important to test the effect of eggs with different composition on markers associated with dyslipidemia, dysglycemia and inflammation. The aim of this study is to assess the effect of n-3PUFA (Omega 3) fortified egg compared to omega-6 Israeli regular egg on metabolic, inflammation and other physiologic parameters.
STUDY OBJECTIVES First endpoint: To assess the effect of high n-3 PUFA (Omega 3) egg, as compared to regular- high n-6 PUFA (Omega 6) Israeli egg, on glycemic levels after night fasting and post prandial of 2 egg breakfast test meal. Secondary endpoint: To compare the effect of high n-3 PUFA fortified egg versus high n-6 PUFA (Regular) egg on measures associated with CVD risks including: CRP, LDL oxidation, MDA, post prandial Flow mediated dilatation (FMD), liver enzymes, and blood lipids and lipoproteins, and further blood chemistry measures. Third endpoint: To assess the influence of n-3 Egg on erythrocytes fatty acid profile. Study design: Prospective, Crossover, Compared Study Study population: 20 Healthy subjects Study Methods: Subjects will complete two study stages. In first stage study participants will get 3 weeks regimen including 2 Regular, Israeli (high n-6 Pufa) eggs/day. In second stage after 3 weeks washout without eggs, study participants will get 3 weeks regimen with 2 high n-3Pufa eggs/day.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Enrollment
20
In second stage participants will receive two Omega-3 enriched hard-boiled eggs/day at breakfast for a three weeks period for each participant.
Rabin Medical Center, Campus Beilinson
Petah Tikva, Petach Tikva, Israel
Glycemic levels
Pre- and Post-prandial (before meal and 30 and 60 minutes after meal) blood glucose test
Time frame: before meal and 30 and 60 minutes after meal
Fatty Acid Composition
ω3 incorporation into blood cell membranes(RBC)
Time frame: Study Days:1,21,43 and 63
C-Reactive protein
measures associated with CVD (Cardiovascular disease) risks
Time frame: Study Days:1, 21, 43 and 63
MDA(Malondialdehyde)
Measures associated with CVD (Cardiovascular disease) risks
Time frame: Study days: 1,21,43 and 63
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.